Halo Labs Announces New Products and Leadership Changes
Dr. Joseph Keegan, Executive Chairman, to Assume Interim Leadership
News
Immunome Announces Exercise in Full and Closing of Over-Allotment Option in Initial Public Offering
Annovis Bio Demonstrates Improved Axonal Transport in Nerve Cells and Brain of Down Syndrome Mice, an Animal Model of Alzheimer’s Disease
Manuscript Published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
Study adds further validation that Annovis’ lead compound is the only drug to improve axonal transport, the information highway of the nerve cell
IVIEW Collaboration With Dr. Amin Javer at St. Paul’s Hospital and Sinus Centre, Canada to Study Povidone Iodine Formulations Including IVIEW-1503, a Long-Lasting Povidone Iodine Nasal Spray for the Treatment of COVID-19
Venatorx Pharmaceuticals Names William Sargent Senior Vice President, Commercial Strategy
Immunome Announces Creation of COVID-19 Advisory Board
Advisory Board to help guide development and clinical testing of biosynthetic convalescent plasma as a potential COVID-19 treatment and prevention of disease
Melior Pharmaceuticals Awarded Grant for Advancing Pulmonary Therapeutic in COVID-19 Phase 2 Clinical Trial
- Melior’s therapeutic candidate, tolimidone, is:
-
- Expected to mitigate the probability and severity of COVID-19 subjects developing severe lung complications
-
- A repositioned drug that has been demonstrated to be safe and well-tolerated in previous clinical studies
Everest Medicines Announces Top-line Results from Phase 1 Clinical Trial of Taniborbactam in Combination with Cefepime in China
Wellsheet Deployed by RWJBarnabas Health Improves Clinical Workflow and Improves Patient Care
Wellsheet Reduces Doctors’ Time in the EHR Chart by 40%